These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8071675)

  • 1. Limitations of and indications for the use of co-trimoxazole.
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1994 Feb; 6(1):3-11. PubMed ID: 8071675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of sulphonamides with diaminopyrimidines: how, when and why?
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1995 Apr; 7(2):136-9. PubMed ID: 7666120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice.
    Spencer RC; Moseley DJ; Greensmith MJ
    J Antimicrob Chemother; 1994 May; 33 Suppl A():121-9. PubMed ID: 7928829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-trimoxazole use restricted.
    Drug Ther Bull; 1995 Dec; 33(12):92-3. PubMed ID: 8777892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
    Klinker H; Langmann P; Zilly M; Richter E
    J Clin Pharm Ther; 1998 Apr; 23(2):149-54. PubMed ID: 9786102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole. Rationale for re-examining its indications for use.
    Howe RA; Spencer RC
    Drug Saf; 1996 Apr; 14(4):213-8. PubMed ID: 8713689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological changes in Pneumocystis carinii in the alveolar space due to treatment with co-trimoxazole--comparison of clinical cases and experimental rats].
    Hibiya I
    Kansenshogaku Zasshi; 1990 Apr; 64(4):455-66. PubMed ID: 2401809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
    Crewe-Brown HH; Reyneke MP; Khoosal M; Becker PJ; Karstaedt AS
    S Afr Med J; 2004 Jun; 94(6):440-2. PubMed ID: 15250455
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A; Murri R; Ammassari A
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract]   [Full Text] [Related]  

  • 11. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.
    Liang RH; Yung RW; Chan TK; Chau PY; Lam WK; So SY; Todd D
    Antimicrob Agents Chemother; 1990 Feb; 34(2):215-8. PubMed ID: 2327768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed drug eruptions due to co-trimoxazole.
    Lim JT; Chan HL
    Ann Acad Med Singap; 1992 May; 21(3):408-10. PubMed ID: 1416793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.
    Ruskin J; LaRiviere M
    Lancet; 1991 Feb; 337(8739):468-71. PubMed ID: 1671479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe and long lasting cholestasis after high-dose co-trimoxazole treatment for Pneumocystis pneumonia in HIV-infected patients--a report of two cases.
    Hanses F; Zierhut S; Schölmerich J; Salzberger B; Wrede CE
    Int J Infect Dis; 2009 Nov; 13(6):e467-9. PubMed ID: 19299179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to co-trimoxazole in HIV infection.
    van der Ven AJ; Koopmans PP; Vree TB; van der Meer JW
    Lancet; 1991 Aug; 338(8764):431-3. PubMed ID: 1678095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron usage in HIV positive patients: a pilot study on the control of nausea and vomiting in patients on high dose co-trimoxazole for Pneumocystis carinii pneumonia.
    Gompels M; McWilliams S; O'Hare M; Harris JR; Pinching AJ; Main J
    Int J STD AIDS; 1993; 4(5):293-6. PubMed ID: 8218517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
    Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
    Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole.
    Price DA; Hollings NP; Janes SM; Main J; Coker RJ
    J Antimicrob Chemother; 1994 Aug; 34(2):303. PubMed ID: 7814298
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children.
    Smellie JM; Grüneberg RN; Bantock HM; Prescod N
    Pediatr Nephrol; 1988 Jan; 2(1):12-7. PubMed ID: 3152984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of co-trimoxazole in developing countries.
    Church JA; Fitzgerald F; Walker AS; Gibb DM; Prendergast AJ
    Lancet Infect Dis; 2015 Mar; 15(3):327-39. PubMed ID: 25618179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.